The Mark Egly Foundation desires to fund specific research with various uses of Alpha1 Antitrypsin to improve the health of individuals with comorbidities. Comorbidities that can be avoided with proper usage of Alpha1 Antitrypsin as a preventative measure to prevent the development of disease and the spread of disease.
The Mark Egly Foundation desires to fund specific research on the development of Alpha1 Antitrypsin through resources other than human blood and plasma donation.
We desire to fund research to have a more exact definition of what strictly medically defines and categorizes what Alpha1 Antitrypsin Deficiency is as a disease or condition.
We desire to fund studies with sound scientific rationale and clear relevance for people with Alpha1 Antitrypsin Deficiency but expand to the 152 Autoimmune diseases outlined in the Mark Egly patent filing of 2020 relating to a plurality of diseases and other previously unknown comorbidities. No idea is too novel for us to consider. We support academic and industry scientists, small biotech firms, big pharmaceutical companies, and medical care professionals. The spectrum of our desired research spans basic and clinical researchers.
Our Foundation has the desire to have our findings expanded to horizons with medical situations and diseases that were not previously considered relevant to Alpha1 Antitrypsin and its deficiency. Example – If there are insufficient levels of Alpha1 Antitrypsin to protect the tissue of the lungs, then there is logically not enough to protect Thrombospondin1 and other items that could affect the formation and development of proper blood cell formation in the bone marrow.
At the Mark Egly Foundation, we will continue to pursue cures, advancements in treatments, and advancements in identifying preventable health conditions from manifesting, including the metastasizing of tumors and cancer!
In the Foundation's pursuit of helping Alpha's identify these related conditions associated with Alpha1 Antitrypsin Deficiency, we will constantly be looking to test and find improved ways to test individuals.